Novozymes A/S
CPSE:NSIS B
kr 380,20
+ kr5,50 (1,47%)
380,20 kr
+kr5,50 (1,47%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
10,46%
5-year Growth Rate
R
4/6
5-year Risk Analysis
O
58,13%
Outlook 12/26
W
21,76%
Margin of safety
T
20,99%
Analyst Price Target
H
DOWN
50-week EMA Trend

Company Info

EPS Growth 5Y
3,22%
Revenue growth 5Y
15,69%
Price growth 5Y
-6,42%
Market Cap
kr177,14 B
Long-Term Debt
kr11,41 B
Quarterly earnings
05/08/2026 (E)
Dividend
kr6,58
Dividend Yield
1,73%
Industry
Country
Website
ISIN Number

Novozymes A/S Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

kr460,00
20.99%
20.99
Last Update: 03/29/2026
Analysts: 17

Highest Price Target kr560,00

Average Price Target kr460,00

Lowest Price Target kr362,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Novozymes A/S
CPSE:NSIS B
1,06% -6,42% 7,48% 10,46% 4/6 58,13% 21,76% 20,99% DOWN
×